A case of anti-GA1 antibody-positive Fisher syndrome with elevated tau protein in cerebrospinal fluid

Brain and Development

Volumn 34, Issue 4, 2012, Pages 329-332

  Oyazato, Yoshinobu ^a   Shiihara, Takashi ^b   Kusunoki, Susumu ^c   Adachi, Masao ^a   Ohnishi, Noriko ^a   Taniguchi, Hiroaki ^a   Nishiyama, Atsushi ^a   Watanabe, Aika ^a   Kobayashi, Mitsuro ^a   Kamioka, Ichiro ^a  

^a Kakogawa West City Hospital   (Japan)

^b Gumna Children S Medical Center   (Japan)

^c KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anti GA1 antibody; Fisher syndrome; Guillain Barr syndrome; Tau protein

Indexed keywords

ANTIBODY; GA1 ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; TAU PROTEIN; UNCLASSIFIED DRUG;

ANTIBODY BLOOD LEVEL; AREFLEXIA; ARTICLE; BINOCULAR CONVERGENCE; CAMPYLOBACTER; CASE REPORT; CEREBROSPINAL FLUID; CHILD; DIPLOPIA; DISEASE SEVERITY; ENTEROCOLITIS; EXTERNAL OPHTHALMOPLEGIA; FECES ANALYSIS; GUILLAIN BARRE SYNDROME; HUMAN; NONHUMAN; NYSTAGMUS; OPHTHALMOPLEGIA; PROGNOSIS; SCHOOL CHILD;

AUTOANTIBODIES; AUTOIMMUNE DISEASES OF THE NERVOUS SYSTEM; CAMPYLOBACTER INFECTIONS; CHILD; GANGLIOSIDES; HUMANS; MALE; MILLER FISHER SYNDROME; TAU PROTEINS; UP-REGULATION;

EID: 84858279658     PISSN: 03877604     EISSN: 18727131     Source Type: Journal    
DOI: 10.1016/j.braindev.2011.06.007     Document Type: Article

References (10)

1. Kaida K., Kanzaki M., Morita D., Kamakura K., Motoyoshi K., Hirakawa M., et al. Anti-ganglioside complex antibodies in Miller Fisher syndrome. J Neurol Neurosurg Psychiatry. 2006, 77:1043-1046.
2. Overell J.R., Hseih S.T., Odaka M., Yuki N., Willson H.J. Treatment for Fisher syndrome, Bickerstaff's brainstem encephalitis and related disorders. Cochrane Database Syst Rev 2007, 24(1):CD004761.
3. Gatterbauer B., Neisser A., Bernheimer H., Schwerer B. Antiglycosphingolipid immune responses in neurology. Ann N Y Acad Sci. 1998, 19:353-362.
4. Brettschneider J., Petzold A., Süssmuth S., Tumani H. Cerebrospinal fluid biomarkers in Guillain-Barré syndrome-Where do we stand?. J Neurol. 2009, 256:3-12.
5. Jin K., Takeda A., Shiga Y., Sato S., Ohnuma A., Nomura H., et al. CSF tau protein: A new prognostic marker for Guillain-Barré syndrome. Neurology 2006, 67:1470-1472.
6. Kusunoki S. Miller Fisher syndrome (in Japanese). Tanpakushitsu Kakusan Koso. 2004, 49:2485-2490.
7. Chiba A., Kusunoki S., Obata H., Machinami R., Kanazawa I. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies. Neurology 1993, 43:1911-1917.
8. Ang C.W., De Klerk M.A., Endtz H.P., Jacobs B.C., Laman J.D., van der Meché F.G., et al. Guillain-Barré syndrome and Miller Fisher syndrome-associated Campylobacter jejuni Lipopolysaccharides induce anti-GM1 and anti-GQ1b antibodies in rabbits. Infect Immun 2001, 69:2462-2469.
9. Petzold A., Brettschneider J., Jin K., Keir G., Murray N.M., Hirsch N.P., et al. CSF protein biomarkers for proximal axonal damage improve prognostic accuracy in the acute phase of Guillain-Barré syndrome. Muscle Nerve 2009, 40:42-49.
10. Süssmuth S.D., Reiber H., Tumani H. Tau protein in cerebrospinal fluid (CSF): a blood-CSF barrier related evaluation in patients with various neurological diseases. Neurosci Lett 2001, 9(300):95-98.